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Background: Obsessive–compulsive disorder (OCD) is one of the leading causes of disability 
and reduced quality of life (QOL), with impairment in a number of domains. However, there 
is a paucity of literature on the association between severity of OCD symptoms and QOL, and 
the data that do exist are inconsistent. In addition, the role of severity in QOL has not been 
summarized as yet from a cross-generational perspective (ie, across childhood/adolescence 
and adulthood). Through meta-regression techniques, the current study summarized evidence 
about the moderator role of severity of OCD symptoms on differences in global QOL between 
individuals with OCD and controls.
Methods: Online databases were searched, and cross-sectional case–control studies comparing 
participants of all ages with OCD with controls on self-report QOL measures were included. 
Random-effect meta-regression techniques were used to comment on the role of illness severity 
in global QOL in individuals with OCD.
Results: Thirteen studies were included. A positive significant association emerged between 
OCD severity and effect sizes on global QOL: in samples with higher severity, there were 
narrower differences in QOL between patients with OCD and controls than in samples with 
lower severity. Such positive association was confirmed by a sensitivity analysis conducted on 
studies including only adults, where the difference in QOL ratings between patients and controls 
was significantly narrower when OCD severity was higher. Conversely, a negative association 
between severity and QOL was found in those studies including only children/adolescents, 
where the difference in QOL was significantly larger between patients and controls when OCD 
severity was higher.
Conclusion: QOL remains an important issue to address in the management of OCD in all age 
groups, irrespective of illness severity. Even in those with lower severity ratings, QOL may be 
considered as an important marker of treatment response.
Keywords: obsessive–compulsive disorder, quality of life, systematic review, symptoms 
severity, well-being, meta-regression
Introduction
Obsessive–compulsive disorder (OCD) – characterized by intrusive, recurrent thoughts, 
impulses, or mental images as well as repetitive overt or covert behaviors – is one 
of the leading sources of disability globally.1 The definition of health by the World 
Health Organization2 emphasizes the importance of subjective experience besides 
absence of disease as an essential component of quality of life (QOL). QOL can be 
conceptualized as “a patient’s perceptions of the impact of disease in a variety of 
dimensions, including physical, mental, and social domains”.3 Besides being one of the 
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measures of the efficacy of existing treatments, the investiga-
tion of QOL appears to be a relevant – yet, not sufficiently 
recognized – topic in OCD research and practice.4,5 There 
is abundant evidence to suggest that QOL is significantly 
reduced in OCD compared to healthy controls.6,7 Even at the 
end of a successful treatment, individuals with OCD can still 
experience poorer QOL than normative samples.8 The only 
patient group with lower perceived QOL than individuals 
with OCD was those with schizophrenia.9
Some heterogeneity was found in the results about the 
relation between OCD and QOL,6,7 and a moderator of 
these findings could be different levels of OCD severity 
of the participants included in different studies. Clinical 
observation would suggest that individuals with higher 
severity experience poorer QOL. In the literature, however, 
few and inconsistent data is available on the association 
between symptom severity and QOL. For example, greater 
severity was related to poorer QOL in some studies,10 but 
this was not confirmed by others.11 In addition, information 
on the role of illness severity in QOL of OCD across dif-
ferent age groups (ie, adult vs children/adolescents) does 
not exist. The currently available research results have not 
yielded conclusive evidence about the association between 
illness severity and QOL. Thus, this inconsistency could 
concern differences related to the age cohorts, because the 
intensity and the direction of the association between QOL 
and severity could be different across adults and children/
adolescents with OCD. On one hand, in adult samples, some 
studies indicated a strong significant inverse association 
between QOL and severity,10 whereas other reported only 
a modest association;12 in others, a significant association 
was not found,11 and in some other studies only obsessions 
severity, but not compulsions, was associated with QOL.13 
On the other hand, in children and adolescent samples, recent 
research more consistently demonstrated inverse relations 
between QOL and OCD symptom severity.14–16 It could be 
hypothesized that young people (children and adolescents) 
and adult groups with OCD have different clinical charac-
teristics and levels of severity, as suggested by previous 
research demonstrating that, compared with adults, children 
and adolescents had considerably more severe aggressive 
obsessions, a higher proportion of males suffering from 
OCD, and lower insight of symptoms, whereas adults had 
stronger sexual obsessions.17 Thus, the generational cohort 
could have an impact on QOL, as the developmental phase 
can be associated with different levels of severity.
Using meta-regression techniques, the present study sum-
marized evidence about the moderating role of OCD severity 
on the differences in global QOL between individuals diag-
nosed with OCD and controls. Given the differences in terms 
of severity between these groups, the role of illness severity 
in QOL was investigated separately for adults and children/
adolescent individuals with OCD. Knowing the role of 
severity in QOL can inform practice and facilitate treatment 
by directing the focus of clinicians to assessing and improving 
QOL as a function of severity presented by the patient.
Methods
Eligibility criteria
According to the PRISMA guidelines18 for observational 
cross-sectional case–control studies, the criteria for inclusion 
of studies involved the following domains.
Participants
Studies were included if conducted on participants who met 
diagnostic criteria for primary OCD. Diagnosis had to be 
made through a semi-structured interview based on stan-
dardized diagnostic criteria, such as the Structured Clinical 
Interview for DSM-IV Axis I disorders (SCID-I).19 Studies 
including participants with a lifetime or subclinical diagnosis 
of OCD were excluded as only current full diagnoses were 
considered. Studies were included if they used outpatients or 
inpatients and if they assessed patients with a diagnosis of 
mild to severe OCD. Participants of all ages were included. 
Studies on primary hoarding were excluded, as it is classified 
as a separate diagnosis in Diagnostic and Statistical Manual 
of Mental Disorders-fifth edition (DSM-5),1 not necessarily 
correlated with OCD, despite being included in the chapter on 
OCD-related disorders. Any psychiatric comorbidity and con-
current treatment – both psychological and pharmacological – 
were not considered as reasons for exclusion. The rationale for 
this was the necessity to allow generalizability of findings to 
real-world practice, as a relevant proportion of patients with 
OCD presents with comorbidities or is under treatment.20
Outcomes
Studies were included if they used self-report validated ques-
tionnaires as measures of global QOL, such as The Medical 
Outcome Study 36-short-form health survey (SF-36).21 
Measures had to assess QOL as a global construct. For those 
measures including subscales related to different domains 
of QOL, a global QOL measure was obtained by pooling 
scores on all the subscales and calculating a mean score as a 
global score. In addition, studies had to report data on OCD 
severity, measured by the Yale Brown Obsessive Compulsive 
Scale (Y-BOCS)22 for adults, or the Children-Yale Brown 
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Obsessive Compulsive Scale (CY-BOCS)23 for children 
and adolescents. The Y-BOCS is the gold standard measure 
to assess severity of OCD in adults – the most widely used 
measure in clinical assessment and trials. This scale con-
sists of 10 items covering the length of time occupied by 
the symptoms, the associated distress, level of impairment, 
extent of resistance, and the extent of control over obses-
sions and compulsions. Each item is scored on a Likert-type 
scale ranging from 0 to 4; total scores of the scale range 
from 0 to 40. Similarly, the CY-BOCS is the gold standard 
measure of severity in children/adolescents, assessed over 
the preceding week with scores from 0 to 40, with higher 
scores indicating increased levels of severity. It is commonly 
used as a primary screening and outcome measure in trials 
for youth with OCD.23
Control groups
Studies were included if the comparator groups included 
screened control participants, who have not reported any 
psychiatric disorder during a clinical interview, or unscreened 
individuals from the general population.
Design
Studies were included if they were based on an observational 
cross-sectional case–control design, where groups of par-
ticipants with primary OCD diagnosis were compared with 
control groups on global QOL.
Information sources and search 
procedure
An online search of literature (published between 1966 and 
August 2017) was carried out. Keywords related to OCD 
(“Obsessive-compulsive disorder”, “obsessions”, “com-
pulsions”, “rituals”) were combined through the Boolean 
operator “AND” with keywords related to QOL (“Quality 
of Life”, “psychological well-being”, “satisfaction with 
life”, “global functioning”, “social functioning”, “family 
functioning”, “subjective well-being”) and with keywords 
related to QOL measures (“Medical Outcome Survey Short 
Form-36”, “Quality of Life Inventory”, “Satisfaction with 
Life Scale”, “WHOQOL-100”, “WHOQOL-BREF”). The 
following databases were searched: PubMed, Science Direct, 
and PsycINFO. Two reviewers (AP and FF) independently 
conducted the systematic search.
Study selection and coding
Studies were assessed on eligibility criteria by two indepen-
dent reviewers (AP and FF) during three different stages. 
When assessing the studies, each reviewer was blind to the 
assessment outcomes of the other reviewer. The contribution 
of each of the reviewers was the assessment of all the studies 
obtained by the search strategy and the screening stages at 
title, at abstract, and at full-text. Moreover, they indepen-
dently coded the included studies, extracted the data, and 
inserted them in a worksheet; finally, each of the two review-
ers independently calculated the summary measures.
During the first and the second stages, the eligibility of 
studies was evaluated after reading the title and the abstract, 
respectively. During these stages, studies were retained 
when there was no agreement on inclusion between the 
reviewers. Finally, the remaining studies were assessed 
on eligibility by reading the full-text article. After each 
stage of the selection, the reviewers discussed reasons 
for inclusion, and potential discrepancies in the judgment 
were addressed during meetings with another independent 
reviewer to obtain a shared pool of included studies for the 
meta-regression study.12,15,27–37
The independent reviewers (AP and FF) coded OCD 
severity as a moderator variable, extracted the data from the 
primary studies, and entered them into an Excel worksheet. 
Subsequently, during meetings with the third reviewer 
(AC), insertion of the data in the worksheets was checked 
for accuracy, and each potential discrepancy was discussed 
and resolved.
OCD severity was coded independently by the reviewers 
(AP and FF) by extracting the mean score of OCD and con-
trol groups on Y-BOCS or CY-BOCS. QOL was coded by 
extracting mean scores and standard deviations (SDs) on all 
the measures of QOL used by the study.
Meta-analysis and meta-regression
Data extraction and summary measures
Because a significant heterogeneity was expected in the effect 
sizes, standardized mean differences (SMDs) in effect sizes 
were calculated using random-effect meta-analyses. Random 
effects models assume that the included studies are drawn 
from populations of studies that systematically differ from 
each other. According to this model, the effect sizes extracted 
from the included studies differ not only because of the 
random error within studies (as in the fixed effects model), 
but also because of true variation in effect sizes from one 
study to the other.24 Data were extracted independently by 
two reviewers (AP and FF) through the following formula:25 
M
OCD
 − M
CONTROL
/SD
POOLED
, where M
OCD
 represents the mean 
of groups with OCD, M
CONTROL
 is the mean of controls, and 
SD
POOLED
 is the pooled SD. Then, the effect size of each 
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study was weighted through the application of the following 
correction formula: W
zr
 = 1/SE2
zr
, where SE2
zr
 is the standard 
error (SE) of the effect size computed for each study. This 
formula was corrected through the following formula for 
sampling error bias: W ′ = W
zr
 (α
QOL
) * (α
OCD
), where α
QOL
 
is the Cronbach’s reliability coefficient for QOL measures 
and α
OCD
 is the coefficient for OCD measures. Effect sizes 
were estimated using a 99% confidence interval (CI) and 
interpreted according to criteria proposed by Cohen:25 values 
equal to 0.80 or higher were interpreted as large, up to 0.50 
as moderate, and up to 0.20 as small. Hedges’ correction for 
small sample bias was applied to all effect sizes.26 Negative 
effect sizes indicated larger differences between individuals 
with OCD and controls, with higher QOL among controls 
than participants with OCD.
A global effect size was calculated as an SMD in effect 
sizes by combining effect sizes related to total scores in dif-
ferent measures of QOL as a global construct. When a study 
reported data on different domains of QOL, such as work, 
social, or family QOL, a mean effect size was calculated 
by pooling mean scores on all domains. Subsequently, sen-
sitivity analyses were conducted for calculating the SMDs 
effect sizes separately for studies including only adults, for 
those including only adolescents/children, and for studies 
including only screened healthy controls without psychi-
atric diagnoses. The rationale for calculating standardized 
estimates separately for adults and children/adolescents 
was the empirical evidence that children and adolescents 
report similar clinical features, whereas adults and children/
adolescents have differences in terms of the severity and 
clinical picture of OCD.17 Meta-regression analyses were 
conducted by calculating weighted least squares meta-
regressions, where dependent variables were SMDs in effect 
sizes of QOL between groups with OCD and controls, and 
independent variables were mean scores on the Y-BOCS or 
the CY-BOCS. In the meta-regression, positive values of 
Beta (β) indicated that higher severity was associated with 
higher SMDs in effect sizes favoring controls, suggesting 
that in samples with higher severity there were higher SMDs 
in effect sizes between individuals with OCD and controls 
favoring the latter group.
To investigate heterogeneity in the SMDs in effect sizes, 
the I 2 and the Q index were used. The I 2 index represents a 
measure of variation in percentage across studies that is attrib-
utable to heterogeneity rather than chance. A value approxi-
mating to zero suggests homogeneity, whereas values of 
25%–50%, 50%–75%, and 75%–100% represent low, medium, 
and large heterogeneities, respectively.24 The Q statistic is 
computed by summing the squared deviations of each study’s 
effect estimate from the overall effect estimate, while weight-
ing the contribution of each study by its inverse variance. 
Under the hypothesis of homogeneity among the effect 
sizes, the Q statistic follows a chi-square distribution with 
k − 1 degrees of freedom, k being the number of studies. 
To investigate the likelihood that effect sizes were subjected 
to publication bias, the Duval and Tweedie’s trim and fill 
procedure and the visual inspection of funnel plot were 
used. The funnel plot represents a scatter plot in which the 
SMDs in effect sizes calculated from the primary studies on 
the horizontal axis are plotted against an indicator of study 
precision, the SE, on the vertical axis.24 In the absence of 
bias, the graph resembles a symmetrical inverted funnel, 
because the SMDs in effect sizes derived from smaller 
studies scatter more widely at the bottom of the graph, 
with the spread narrowing with increasing precision among 
larger studies. If there is publication bias because smaller 
studies that report no significant SMDs in effect sizes remain 
unpublished, then the funnel plot appears asymmetrical.24 
The meta-analysis was run by Comprehensive Meta-analysis 
software, version 2.00.
Results
Process of selection of the studies
The electronic search produced 1,067 records after duplicates 
were removed. Of those studies, 1,015 were excluded on the 
basis of their titles or abstract content, as they focused on 
irrelevant constructs. Thus, 52 were screened at the full-text 
stage. Of those, 39 were excluded in consideration of the eli-
gibility criteria. Specifically, nine were excluded for various 
reasons, including not reporting sufficient data to calculate 
effect sizes (eg, SDs) or to conduct the meta-regression (eg, 
scores on the Y-BOCS or the CY-BOCS were not reported), 
and not replying to invitations to provide the necessary data 
to the present authors. In addition, two studies were excluded 
as they did not include measures of QOL, and three studies 
were excluded as they did not use validated QOL measures. 
Twenty studies were excluded as they did not use a case–
control design (ie, the study did not use a control group). 
Two studies were excluded as they used participants with 
a lifetime OCD diagnosis but without a concurrent OCD 
diagnosis. Two studies were excluded as one study included 
participants with subclinical OCD symptoms and the other 
included participants with a hoarding disorder. Another 
publication was excluded as it used the same data as those 
reported in a study already included in the meta-analysis. 
Finally, 13 studies remained and were included in the 
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meta-regression (n = 1,785,282 effect sizes overall) by con-
sensus of the three independent reviewers. The flow chart 
describing the selection process is presented in Figure 1.
Characteristics of the included studies
All included studies were published in peer-reviewed 
journals.11,27–37 All studies included patients with current pri-
mary OCD, and a healthy control cohort. Ten studies included 
adults,27,30–36 one included children,28 one adolescents,37 
and one focused its analysis on adults and adolescents.29 
Participants in OCD groups were outpatients in all studies. 
Only two studies reported whether patients were on con-
current pharmacological treatments.29,34 Only three studies 
reported the number of individuals with comorbid personality 
disorders (51% in one study and 0% in two studies). The 
studies were globally representative, with four having been 
conducted in European countries,14,27,31,36 six in American 
countries,11,28,30,31,34,37 and three in Asia.29,33,35 The description 
of the characteristics of each study is given in Table 1.
Comparison on QOL between individuals 
with OCD and controls
This analysis included 13 studies (n = 17,852). Results 
showed a large negative SMD in effect sizes favoring indi-
viduals with OCD (SMD = −0.87, SE = 0.20, 95% CI: −1.26 
to 0.48, p  0.0001), showing that individuals with OCD 
had significantly lower global QOL than controls. A large 
heterogeneity in the effect sizes of the studies was found 
(I2 = 95.29, Q
(12)
 = 254.86, p  0.0001). A forest plot which 
indicates the effect sizes of each study and the mean effect 
size is presented in Figure 2. Evidence for publication bias 
was not found, as suggested by the non-significant finding of 
the Egger test (Intercept = −0.54, SE = 2.97, 95% CI: −7.08 
to 6.00, t
(11)
 = 0.18, two-tailed p = 0.85). A funnel plot of 
publication bias for this comparison is provided in Figure 3, 
depicting the SEs of each study as a function of their cor-
responding effect sizes, indicated as SMDs in effect sizes.
Meta-regression of QOL as a function of 
OCD severity in the total OCD cohort
Because large heterogeneity was found in the meta-analysis 
comparing QOL between individuals with OCD and controls, 
a meta-regression of QOL as a function of illness severity 
was run in the OCD cohort. A positive significant association 
emerged between OCD severity and SMDs in effect sizes 
on QOL (β = 0.10, SE = 0.01, 99% CI: 0.09–0.11, k = 82, 
n = 162,590, p  0.01), indicating that higher scores on OCD 
severity were associated with positive SMDs in effect sizes: 
samples with higher OCD severity reported narrower differ-
ences in QOL among participants with OCD and controls. 
Narrower differences suggested lower differences in terms 
of QOL between the patient groups and the controls. Such 
a positive association was confirmed (β = 0.18, SE = 0.01, 
99% CI: 0.16–0.20, p  0.01) when sensitivity analysis was 
run including only screened controls (k = 31, n = 3,733) and 
excluding controls recruited from the general population. 
2,050 records identified through online database search:
PubMed (published between 1966 and August 2017),
Science Direct (published between 1966 and August 2017),
PsycINFO (published between 1966 and August 2017)
1,067 records after duplicates removed
1,067 records screened
52 full-text articles assessed for eligibility
13 studies included in the meta-regression
1,015 records excluded at title or abstract
39 of the full-text articles were excluded for:
–  additional data requested from authors without reply (n = 9)
–  no measures of quality of life reported (n = 2)
–  study not based on a case–control design (n = 20)
–  measures of quality of life not validated (n = 3)
–  participants with lifetime OCD diagnosis (n = 2)
–  participants with subclinical OCD symptoms (n =1)
–  participants with hoarding disorder (n = 1)
–  study conducted on the same data (n = 1)
Figure 1 PRISMA flowchart of the study selection.
Abbreviation: OCD, obsessive–compulsive disorder.
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Illness severity and quality of life in OCD
A meta-regression of global QOL as a function of OCD 
severity is presented in Figure 4.
Meta-regression of QOL on severity 
in adults and children/adolescents 
separately
When a sensitivity analysis was carried out, including only 
studies on adults, a positive association was still found 
(β = 0.10, SE = 0.01, 99% CI: 0.09–0.11, p  0.01). When 
the analysis was restricted to children/adolescent samples, a 
negative association emerged (k = 6, n = 1,178) (β = −1.06, 
SE = 0.20, 99% CI: −1.46 to 0.65, p  0.01), indicating that 
higher scores on severity were associated with wider, nega-
tive SMDs in effect sizes: samples with higher OCD severity 
reported wider differences on QOL among participants with 
OCD and controls favoring controls. Wider negative stan-
dardized differences in means favoring controls suggested 
that, for samples with higher severity, controls had higher 
mean scores than patients with OCD.
Discussion
In the current literature, findings on the association between 
illness severity of OCD symptoms and QOL are limited and 
inconsistent across studies, and a systematic review with 
meta-regression is not yet available. In addition, differences 
in the role of illness severity in QOL were not summarized 
across cohorts of adults and children/adolescents. Knowing 
these aspects can inform routine practice by focusing clini-
cians on assessing and improving QOL according to the 
severity presented by the patient. The current study used 
meta-regression techniques to provide a quantitative synthe-
sis about the role of severity as a moderator of the differences 
in global QOL between individuals with OCD and controls. 
In addition, OCD severity was investigated separately for 
cohorts of adults and children/adolescents.
Thirteen case–control cross-sectional studies were 
included, where clinical groups with a diagnosis of OCD were 
compared with control groups from the general population. 
Severity of symptoms was assessed through the gold standard 
measures of OCD, the Y-BOCS, or the CY-BOCS. Results 
indicated a moderate negative effect size favoring control 
groups without evidence of publication bias: individuals 
with OCD had significantly lower QOL than controls. These 
findings were consistent with clinical impressions, suggesting 
that suffering from OCD can negatively impact the subjec-
tive experience of health. In addition, such results supported 
previous evidence that suggested a significant impairment 
in QOL among individuals with OCD confirming that this Vi
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Figure 2 Forest plot between groups with OCD and controls on global QOL (n = 13).
Abbreviations: CI, confidence interval; OCD, obsessive–compulsive disorder; PQL, Pediatric Quality of Life Inventory – Child Report; QOL, quality of life; SMD, standardized 
mean difference.
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Figure 3 Funnel plot of publication bias for the meta-analysis between groups with OCD and controls on global QOL.
Abbreviations: OCD, obsessive–compulsive disorder; QOL, quality of life; SMD, standardized mean difference.
Figure 4 Meta-regression of global QOL as a function of OCD severity.
Abbreviations: OCD, obsessive–compulsive disorder; QOL, quality of life; SMD, standardized mean difference.
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Illness severity and quality of life in OCD
condition is associated with a lack of subjective experience 
of health and well-being and not merely the presence of 
negative symptoms.6,7,30
Subsequently, because a large heterogeneity in the values 
of the SMDs in effects sizes was observed across the studies, 
a meta-regression was run with entering OCD severity as an 
independent variable and SMDs in effect sizes of global QOL 
as the outcome or dependent variable. Findings showed a 
significant positive association between the severity of OCD 
symptoms and SMDs in effect sizes in global QOL, indicating 
that, in studies with higher severity of OCD symptoms, the 
differences in global QOL between individuals with OCD 
and controls were less than the differences in global QOL 
between individuals with OCD with lower mean illness 
severity and controls. These findings were supported in a 
sensitivity analysis, where only studies with screened con-
trol groups were included and unscreened participants were 
removed. These findings appeared surprising and unexpected 
as clinical observations would suggest that individuals with 
more severe illness symptoms have poorer QOL than those 
with less severity. In addition, these results appeared in con-
trast with some previous studies in the literature reporting 
a negative relationship between OCD severity and QOL,10 
where higher severity of OCD correlated with poorer QOL. 
However, this explanation cannot be conclusive as the cur-
rent study did not control for OCD duration or age onset as 
indicators of chronicity. In addition, it could be expected 
that more severe individuals have lower life expectations 
than those with mild to moderate symptoms, and this would 
lead them to report higher perceptions of QOL. Moreover, it 
could be hypothesized that those individuals with more severe 
symptoms have a poorer insight of the disorder and its effects 
on QOL, because a poorer insight has been found to be a pre-
dictor of stronger treatment resistance and higher severity.38 
Obsessions and compulsions, which are typically pervasive 
in more severe patients, can become a relevant part of their 
identity and personal values, and the most severe patients 
can view them as necessary and useful to maintain well-
being. Thus, the attention of clinicians should be directed 
particularly to stimulate self-awareness of effects of OCD 
on QOL and to develop new values and life roles – different 
from those exclusively based on obsessions and compulsive 
behaviors. Again, due to the lack of studies investigating 
this aspect, insight was not accounted as potentially related 
to severity and QOL. A clinical implication could be the 
use of value-based psychotherapeutic components of the 
Acceptance and Commitment Therapy39 – a form of therapy 
aimed to promoting the development of personal values as 
a therapeutic process. Another clinical implication of these 
findings could be the use of well-being therapy40 as a form 
of intervention particularly directed at improving perceptions 
of QOL. This form of psychotherapy – originally created for 
subclinical symptoms of depression – could be used for those 
individuals with less severe symptoms. Patients with less 
severe symptoms should be taken into account as a particu-
larly vulnerable subgroup in terms of QOL, who should be 
provided with additional skills necessary to develop a better 
perception or appreciation of QOL. In contrast to the com-
mon belief that the severe patients are more vulnerable, thus 
needing more intensive treatments, these findings suggested 
that those with lower illness severity are also a vulnerable 
cohort with reduced QOL. It could be hypothesized that those 
individuals having less severe symptoms, who typically can 
continue working or having social relations despite OCD, 
would have strong awareness of the daily negative effects of 
OCD and experience a more intense sense of social stigma 
than those individuals with more severe OCD and those 
with weaker insight. In conclusion, comorbidity (eg, specific 
types of comorbidities or the number of comorbid disorders), 
stressors (eg, financial, educational, marital stressors, lack 
of support, etc), and the level of insight could be assessed 
in future research as moderators of the relationship between 
illness severity and OCD.
Subsequently, a sensitivity analysis was run, computing 
SMDs in effect sizes with studies on adults only. A further 
analysis was conducted with studies including only cohorts 
of adolescents/children. Although a positive association was 
found between severity of OCD symptoms and standardized 
differences of effect sizes, it became negative when the analy-
sis was restricted to children and adolescent samples. In the 
latter samples, a negative association indicated that higher 
levels of OCD severity were associated with lower differ-
ences in mean effect sizes: samples where OCD severity was 
higher then reported lower global QOL among participants 
with OCD than controls. Evidence of a negative association 
between illness severity and QOL in children/adolescents 
makes clinical sense, but appears inconsistent with empirical 
and clinical observations that, in some youth – particularly 
children – there is generally poorer insight of OCD symptoms 
and lesser awareness of their consequences in daily life as 
compared with adults.1,17 It could be expected that a variable 
like family accommodation, particularly present in youth 
with more severe OCD, can moderate the relation between 
OCD severity and QOL; because, for children with higher 
 
N
eu
ro
ps
yc
hi
at
ric
 D
ise
as
e 
an
d 
Tr
ea
tm
en
t d
ow
nl
oa
de
d 
fro
m
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
19
3.
20
5.
6.
11
1 
on
 1
8-
Ap
r-2
01
8
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Neuropsychiatric Disease and Treatment 2018:14submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1022
Pozza et al
severity, family accommodation is stronger and this can make 
the child/adolescent less aware of symptoms and their effects 
on QOL.40 Family accommodation can manifest in various 
forms including modifying family routines, engaging in the 
patient’s compulsions, and facilitating avoidance of OCD 
triggers – thereby maintaining OCD symptomatology by 
disallowing the individuals to face their feared situations.41
Limitations and conclusion
Some limitations should be highlighted. As previously men-
tioned, other variables – potentially associated with QOL 
and severity, such as insight, symptoms duration, and family 
accommodation – were not considered, because this informa-
tion was lacking in most of the studies we included. Further 
studies investigating the role of these variables are needed. 
Another limitation concerned the cross-sectional design of 
the studies: future longitudinal studies should investigate 
whether severity is prospectively associated with QOL. 
Moreover, the cross-sectional nature of the study prevented 
drawing firm conclusions about the causal relations between 
OCD and QOL. Another relevant shortcoming concerned the 
small number of studies including children and adolescents, 
which could be associated with a poor statistical power of the 
analysis; this highlights the need for further studies evaluating 
QOL in young people with OCD. Finally, specific domains 
of QOL were not investigated due to the small number of 
studies assessing them, such as QOL within the domains of 
social and family relationships.
In conclusion, the current study was the first one using 
meta-regression techniques to summarize evidence about the 
role of illness severity in global QOL in individuals diag-
nosed with OCD. In adults, the difference in QOL measures 
between patients and controls was significantly less when 
OCD severity was higher; conversely, in children/adoles-
cents, the difference in QOL was significantly more between 
patients and controls when OCD severity was higher. QOL 
remains an important issue to address in the management of 
OCD in all age groups, irrespective of illness severity. Even 
in those with lower severity ratings, QOL may be considered 
an important marker of treatment response.
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